WebAug 1, 2023 · What’s new at MannKind. MannKind Corporation Reports 2023 Third Quarter Financial Results. MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes. MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023.
Web0.19%. $257.66B. MNKD | Complete MannKind Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
DA:1PA:64MOZ Rank:13
MannKind Corp (MNKD) Stock Price & News - Google Finance
WebReported on 11/7/23. Get the latest MannKind Corp (MNKD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...
DA:86PA:75MOZ Rank:53
MannKind Corporation Reports 2022 Fourth Quarter and Full …
WebGet the latest MannKind Corporation (MNKD) stock news and headlines to help you in your trading and investing decisions. ... Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq ...